In a report released today, Charles Bentley, CFA from Jefferies maintained a Buy rating on Croda International (CRDA – Research Report), with a price target of p5,000.00. The company’s shares ...

HL Building Blocks Build your own portfolio with HL's specially designed fund range Wealth Shortlist A selection of funds we've researched and chosen for their long-term potential ...

Croda reported an adjusted pre-tax profit of £273.1m at constant currency for the 12 months to 31 December, down 11.6% on the year before but in line with the £260m-280m guidance range.

Croda International reported a slight decline in sales for 2024, with revenue falling one per cent at constant currency to £1.63bn. Excluding Covid-19-related lipid sales from 2023, underlying ...

Croda delivered 2024 adjusted profit before tax of GBP 260 million, at the low end of its target range and broadly aligned with our forecast. Management expects some recovery in 2025 but remains ...

Trading profit for the year rose 8.2% to a bigger than expected $1.05 billion. Speciality chemicals firm Croda International and student accommodation firm Unite also reported results, with their ...

Croda will share it’s full-year results as the company passes 100 years. Despite the longevity of the brand, recent years have provided challenges, with the share price dropping over a third in the ...

The projected fair value for Croda International is UK£24.72 based on 2 Stage Free Cash Flow to Equity Current share price of UK£32.20 suggests Croda International is potentially 30% overvalued ...

Over 300 people have signed an online petition calling for Surrey County Council and the NHS to "recognise the need for a chemist in Thames Ditton". Karen Randolph, who started the campaign ...

UBS analyst Charles Eden maintained a Buy rating on Croda International (CRDA – Research Report) today and set a price target of p5,100.00. The company’s shares opened today at p3,113.00.